IMMATICS NV (IMTX:NASDAQ)
$10.43 -0.23 (-2.1576%)
Analysed IMMATICS NV (IMTX:NASDAQ) News Sources
Immatics Phase 3 Progress Sharpens View On Anzu Cel Launch Upside
15-03-2026
yahoo.com
Immatics N.V. (IMTX) Seeing Strong Enrollment in a Key Phase 3 Trial of Drug Candidate
13-03-2026
yahoo.com
Immatics: Q4 Earnings Snapshot
05-03-2026
yahoo.com
Immatics Announces Full Year 2025 Financial Results and Business Update
05-03-2026
yahoo.com
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
26-02-2026
yahoo.com
Institutional investors own a significant stake of 38% in Immatics N.V. (NASDAQ:IMTX)
15-01-2026
yahoo.com
Biotech Sector Poised for Growth Driven by Trial Data, Pharma Deals, BofA Says
06-01-2026
yahoo.com
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
11-12-2025
yahoo.com
Immatics (NasdaqCM:IMTX) Valuation Check After Follow-On Share Offering Announcement
06-12-2025
yahoo.com
Immatics Announces $125 Million Underwritten Offering
05-12-2025
yahoo.com
What is the current price of IMMATICS NV (IMTX:NASDAQ)?
The current price of IMMATICS NV (IMTX:NASDAQ) is $10.43.
IMMATICS NV (IMTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMATICS NV (IMTX:NASDAQ) since the previous trading day is $-0.23.
IMMATICS NV (IMTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMATICS NV (IMTX:NASDAQ) since the previous trading day is -2.1576%.
What is the most recent average sentiment score for IMMATICS NV (IMTX:NASDAQ)?
The most recent average sentiment score for IMMATICS NV (IMTX:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for IMMATICS NV (IMTX:NASDAQ)?
The most recent sentiment for IMMATICS NV (IMTX:NASDAQ) is .
SEC-8K** Filing Available For IMMATICS NV (IMTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.